AbbVie Inc. SEC filings ABBV

AbbVie Inc. has 1,006 filings in SEC EDGAR's recent list, going back to May 9, 2017. Its latest annual report, Form ARS, was filed on Mar 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 2, 2026 (officer or director change). The company's fiscal year ends on December 31.

AbbVie Inc. SEC filings
Form Description Filed Period
3 Initial insider ownership Oct 23, 2026 Oct 14, 2026
4 Insider transaction Oct 2, 2026 Sep 30, 2026
4 Insider transaction Oct 2, 2026 Sep 30, 2026
4 Insider transaction Aug 18, 2026 Aug 14, 2026
144 Notice of proposed sale Aug 14, 2026 —
4 Insider transaction Jul 2, 2026 Jul 1, 2026
4 Insider transaction Jul 2, 2026 Jun 30, 2026
144 Notice of proposed sale May 26, 2026 —
4 Insider transaction May 12, 2026 May 8, 2026
4 Insider transaction May 12, 2026 May 8, 2026
4 Insider transaction May 12, 2026 May 8, 2026
4 Insider transaction May 12, 2026 May 8, 2026
4 Insider transaction May 12, 2026 May 8, 2026
4 Insider transaction May 12, 2026 May 8, 2026
4 Insider transaction May 12, 2026 May 8, 2026
4 Insider transaction May 12, 2026 May 8, 2026
4 Insider transaction May 12, 2026 May 8, 2026
4 Insider transaction May 12, 2026 May 8, 2026
4 Insider transaction May 12, 2026 May 8, 2026
SCHEDULE 13G Ownership over 5% (passive) Apr 29, 2026 —
4 Insider transaction Apr 2, 2026 Mar 31, 2026
4 Insider transaction Apr 2, 2026 Mar 31, 2026
4 Insider transaction Apr 2, 2026 Mar 31, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 26, 2026 —
4/A Filing Mar 11, 2026 Feb 27, 2026
4 Insider transaction Mar 6, 2026 Mar 4, 2026
144 Notice of proposed sale Mar 6, 2026 —
4 Insider transaction Mar 6, 2026 Feb 27, 2026
4 Insider transaction Mar 3, 2026 Feb 27, 2026
4 Insider transaction Mar 3, 2026 Feb 27, 2026
4 Insider transaction Mar 3, 2026 Feb 27, 2026
4 Insider transaction Mar 3, 2026 Feb 27, 2026
4 Insider transaction Mar 3, 2026 Feb 27, 2026
4 Insider transaction Mar 3, 2026 Feb 27, 2026
4 Insider transaction Mar 3, 2026 Feb 27, 2026
4 Insider transaction Mar 3, 2026 Feb 27, 2026
144 Notice of proposed sale Mar 2, 2026 —
4 Insider transaction Feb 27, 2026 Feb 25, 2026
144 Notice of proposed sale Feb 25, 2026 —
4 Insider transaction Feb 20, 2026 Feb 18, 2026
4 Insider transaction Feb 20, 2026 Feb 18, 2026
4 Insider transaction Feb 20, 2026 Feb 18, 2026
4 Insider transaction Feb 20, 2026 Feb 18, 2026
4 Insider transaction Feb 20, 2026 Feb 18, 2026
4 Insider transaction Feb 20, 2026 Feb 18, 2026
4 Insider transaction Feb 20, 2026 Feb 18, 2026
4 Insider transaction Feb 20, 2026 Feb 18, 2026
4 Insider transaction Feb 20, 2026 Feb 18, 2026
4 Insider transaction Jan 5, 2026 Dec 31, 2025
4 Insider transaction Jan 5, 2026 Dec 31, 2025
4 Insider transaction Jan 5, 2026 Dec 31, 2025
4 Insider transaction Oct 2, 2025 Sep 30, 2025
4 Insider transaction Oct 2, 2025 Sep 30, 2025
4 Insider transaction Oct 2, 2025 Sep 30, 2025
144 Notice of proposed sale Aug 22, 2025 —
144 Notice of proposed sale Aug 21, 2025 —
4 Insider transaction Aug 14, 2025 Aug 12, 2025
144 Notice of proposed sale Aug 12, 2025 —
144 Notice of proposed sale Aug 8, 2025 —
4 Insider transaction Aug 7, 2025 Aug 5, 2025
144 Notice of proposed sale Aug 5, 2025 —
3/A Ownership document Jul 30, 2025 Jul 1, 2025
3 Initial insider ownership Jul 11, 2025 Jul 1, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 7, 2025 —
4 Insider transaction Jul 2, 2025 Jun 30, 2025
4 Insider transaction Jul 2, 2025 Jun 30, 2025
4 Insider transaction Jul 2, 2025 Jun 30, 2025
4 Insider transaction May 13, 2025 May 9, 2025
4 Insider transaction May 13, 2025 May 9, 2025
4 Insider transaction May 13, 2025 May 9, 2025
4 Insider transaction May 13, 2025 May 9, 2025
4 Insider transaction May 13, 2025 May 9, 2025
4 Insider transaction May 13, 2025 May 9, 2025
4 Insider transaction May 13, 2025 May 9, 2025
4 Insider transaction May 13, 2025 May 9, 2025
4 Insider transaction May 13, 2025 May 9, 2025
4 Insider transaction May 13, 2025 May 9, 2025
4 Insider transaction May 13, 2025 May 9, 2025
4 Insider transaction May 13, 2025 May 9, 2025
4 Insider transaction May 13, 2025 May 9, 2025
3 Initial insider ownership May 13, 2025 May 9, 2025
4 Insider transaction Apr 2, 2025 Mar 31, 2025
4 Insider transaction Apr 2, 2025 Mar 31, 2025
4 Insider transaction Apr 2, 2025 Mar 31, 2025
4 Insider transaction Apr 2, 2025 Mar 31, 2025
4 Insider transaction Apr 2, 2025 Mar 31, 2025
144 Notice of proposed sale Mar 31, 2025 —
4 Insider transaction Mar 18, 2025 Mar 14, 2025
144 Notice of proposed sale Mar 14, 2025 —
3 Initial insider ownership Mar 10, 2025 Mar 1, 2025
4 Insider transaction Mar 4, 2025 Feb 28, 2025
4 Insider transaction Mar 4, 2025 Feb 28, 2025
4 Insider transaction Mar 4, 2025 Feb 28, 2025
4 Insider transaction Mar 4, 2025 Feb 28, 2025
4 Insider transaction Mar 4, 2025 Feb 28, 2025
4 Insider transaction Mar 4, 2025 Feb 28, 2025
4 Insider transaction Mar 4, 2025 Feb 28, 2025
4 Insider transaction Mar 4, 2025 Feb 28, 2025
4 Insider transaction Mar 4, 2025 Feb 28, 2025
4 Insider transaction Mar 4, 2025 Feb 28, 2025
144 Notice of proposed sale Mar 3, 2025 —
144 Notice of proposed sale Mar 3, 2025 —
144 Notice of proposed sale Mar 3, 2025 —
144 Notice of proposed sale Feb 28, 2025 —
4 Insider transaction Feb 28, 2025 Feb 26, 2025
4 Insider transaction Feb 28, 2025 Feb 26, 2025
144 Notice of proposed sale Feb 28, 2025 —
144 Notice of proposed sale Feb 26, 2025 —
144 Notice of proposed sale Feb 26, 2025 —
4 Insider transaction Feb 24, 2025 Feb 20, 2025
144 Notice of proposed sale Feb 20, 2025 —
4 Insider transaction Feb 18, 2025 Feb 13, 2025
4 Insider transaction Feb 18, 2025 Feb 13, 2025
4 Insider transaction Feb 18, 2025 Feb 13, 2025
4 Insider transaction Feb 18, 2025 Feb 13, 2025
4 Insider transaction Feb 18, 2025 Feb 13, 2025
4 Insider transaction Feb 18, 2025 Feb 13, 2025
4 Insider transaction Feb 18, 2025 Feb 13, 2025
4 Insider transaction Feb 18, 2025 Feb 13, 2025
4 Insider transaction Feb 18, 2025 Feb 13, 2025
4 Insider transaction Feb 18, 2025 Feb 13, 2025
SCHEDULE 13G Ownership over 5% (passive) Feb 18, 2025 —
4/A Filing Feb 7, 2025 Feb 15, 2024
4 Insider transaction Jan 3, 2025 Dec 31, 2024
4 Insider transaction Jan 3, 2025 Dec 31, 2024
4 Insider transaction Jan 3, 2025 Dec 31, 2024
4 Insider transaction Dec 18, 2024 Dec 16, 2024
144 Notice of proposed sale Dec 16, 2024 —
4 Insider transaction Oct 2, 2024 Sep 30, 2024
4 Insider transaction Oct 2, 2024 Sep 30, 2024
4 Insider transaction Oct 2, 2024 Sep 30, 2024
4 Insider transaction Oct 2, 2024 Sep 30, 2024
4 Insider transaction Sep 30, 2024 Sep 24, 2024
144 Notice of proposed sale Aug 8, 2024 —
4 Insider transaction Aug 7, 2024 Aug 5, 2024
144 Notice of proposed sale Aug 7, 2024 —
144 Notice of proposed sale Aug 5, 2024 —
4 Insider transaction Jul 19, 2024 Jul 17, 2024
144 Notice of proposed sale Jul 17, 2024 —
4 Insider transaction Jul 2, 2024 Jun 30, 2024
4 Insider transaction Jul 2, 2024 Jun 30, 2024
4 Insider transaction Jul 2, 2024 Jun 30, 2024
4 Insider transaction Jul 2, 2024 Jun 28, 2024
4 Insider transaction May 7, 2024 May 3, 2024
4 Insider transaction May 7, 2024 May 3, 2024
4 Insider transaction May 7, 2024 May 3, 2024
4 Insider transaction May 7, 2024 May 3, 2024
4 Insider transaction May 7, 2024 May 3, 2024
4 Insider transaction May 7, 2024 May 3, 2024
4 Insider transaction May 7, 2024 May 3, 2024
4 Insider transaction May 7, 2024 May 3, 2024
4 Insider transaction May 7, 2024 May 3, 2024
4 Insider transaction May 7, 2024 May 3, 2024
4 Insider transaction May 7, 2024 May 3, 2024
4 Insider transaction May 7, 2024 May 3, 2024
4 Insider transaction Apr 2, 2024 Mar 31, 2024
4 Insider transaction Apr 2, 2024 Mar 31, 2024
4 Insider transaction Apr 2, 2024 Mar 31, 2024
4 Insider transaction Mar 22, 2024 Mar 20, 2024
144/A Filing Mar 21, 2024 —
144 Notice of proposed sale Mar 20, 2024 —
4 Insider transaction Mar 20, 2024 Mar 18, 2024
144 Notice of proposed sale Mar 18, 2024 —
4 Insider transaction Mar 5, 2024 Mar 1, 2024
144 Notice of proposed sale Mar 1, 2024 —
4 Insider transaction Mar 1, 2024 Feb 23, 2024
4 Insider transaction Mar 1, 2024 Feb 28, 2024
4 Insider transaction Mar 1, 2024 Feb 28, 2024
4 Insider transaction Mar 1, 2024 Feb 28, 2024
4 Insider transaction Mar 1, 2024 Feb 28, 2024
4 Insider transaction Mar 1, 2024 Feb 28, 2024
4 Insider transaction Mar 1, 2024 Feb 28, 2024
4 Insider transaction Mar 1, 2024 Feb 28, 2024
4 Insider transaction Mar 1, 2024 Feb 28, 2024
4 Insider transaction Mar 1, 2024 Feb 28, 2024
4 Insider transaction Mar 1, 2024 Feb 28, 2024
144 Notice of proposed sale Mar 1, 2024 —
144 Notice of proposed sale Feb 29, 2024 —
144 Notice of proposed sale Feb 29, 2024 —
4 Insider transaction Feb 29, 2024 Feb 27, 2024
144 Notice of proposed sale Feb 29, 2024 —
144 Notice of proposed sale Feb 28, 2024 —
4 Insider transaction Feb 27, 2024 Feb 23, 2024
4 Insider transaction Feb 23, 2024 Feb 21, 2024
144 Notice of proposed sale Feb 23, 2024 —
144 Notice of proposed sale Feb 21, 2024 —
4 Insider transaction Feb 20, 2024 Feb 15, 2024
4 Insider transaction Feb 20, 2024 Feb 15, 2024
4 Insider transaction Feb 20, 2024 Feb 15, 2024
4 Insider transaction Feb 20, 2024 Feb 15, 2024
4 Insider transaction Feb 20, 2024 Feb 15, 2024
4 Insider transaction Feb 20, 2024 Feb 15, 2024
4 Insider transaction Feb 20, 2024 Feb 15, 2024
4 Insider transaction Feb 20, 2024 Feb 15, 2024
4 Insider transaction Feb 20, 2024 Feb 15, 2024
4 Insider transaction Feb 20, 2024 Feb 15, 2024
4 Insider transaction Feb 20, 2024 Feb 15, 2024
SC 13G/A Amended ownership over 5% (passive) Feb 13, 2024 —
4 Insider transaction Feb 6, 2024 Feb 2, 2024
144 Notice of proposed sale Feb 2, 2024 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
ABBV (NYSE)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
North Chicago, IL
SEC filer status
Large accelerated filer
SEC CIK
1551152

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.